{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:09:22Z","timestamp":1789646962947,"version":"4.0.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-90818-2","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T02:34:42Z","timestamp":1741746882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association between the NHHR and hepatic steatosis and liver fibrosis: a population-based study"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiaoxian","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"90818_CR1","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.3390\/ijms21165888","volume":"21","author":"A Lonardo","year":"2020","unstructured":"Lonardo, A., Leoni, S., Alswat, K. A. & Fouad, Y. History of nonalcoholic fatty liver disease. Int. J. Mol. Sci. 21, 5888. https:\/\/doi.org\/10.3390\/ijms21165888 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"90818_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100261","volume":"3","author":"OT Ayonrinde","year":"2021","unstructured":"Ayonrinde, O. T. Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past. JHEP Rep.: Innovat. Hepatol. 3, 100261. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100261 (2021).","journal-title":"JHEP Rep.: Innovat. Hepatol."},{"key":"90818_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","volume":"18","author":"N Tamaki","year":"2022","unstructured":"Tamaki, N., Ajmera, V. & Loomba, R. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nat. Rev. Endocrinol. 18, 55\u201366. https:\/\/doi.org\/10.1038\/s41574-021-00584-0 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"90818_CR4","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1007\/s00705-017-3498-7","volume":"162","author":"SS Youssef","year":"2017","unstructured":"Youssef, S. S. & Hamdy, N. M. SOCS1 and pattern recognition receptors: TLR9 and RIG-I; novel haplotype associations in Egyptian fibrotic\/cirrhotic patients with HCV genotype 4. Adv. Virol. 162, 3347\u20133354. https:\/\/doi.org\/10.1007\/s00705-017-3498-7 (2017).","journal-title":"Adv. Virol."},{"key":"90818_CR5","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00705-021-04981-8","volume":"166","author":"NA Ali","year":"2021","unstructured":"Ali, N. A., Hamdy, N. M., Gibriel, A. A. & El Mesallamy, H. O. Investigation of the relationship between CTLA4 and the tumor suppressor RASSF1A and the possible mediating role of STAT4 in a cohort of Egyptian patients infected with hepatitis C virus with and without hepatocellular carcinoma. Adv. Virol. 166, 1643\u20131651. https:\/\/doi.org\/10.1007\/s00705-021-04981-8 (2021).","journal-title":"Adv. Virol."},{"key":"90818_CR6","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A. & Bacon, B. R. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94, 2467\u20132474. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.01377.x (1999).","journal-title":"Am. J. Gastroenterol."},{"key":"90818_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/hep.31608","volume":"73","author":"MT Long","year":"2021","unstructured":"Long, M. T. et al. Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: The framingham heart study. Hepatology (Baltimore, Md.) 73, 548\u2013559. https:\/\/doi.org\/10.1002\/hep.31608 (2021).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"90818_CR8","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/s2468-1253(22)00008-5","volume":"7","author":"LA D\u00edaz","year":"2022","unstructured":"D\u00edaz, L. A. et al. The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas. Lancet Gastroenterol. Hepatol. 7, 552\u2013559. https:\/\/doi.org\/10.1016\/s2468-1253(22)00008-5 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"90818_CR9","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/s0140-6736(21)01374-x","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s, P. et al. Liver cirrhosis. Lancet (London, England) 398, 1359\u20131376. https:\/\/doi.org\/10.1016\/s0140-6736(21)01374-x (2021).","journal-title":"Lancet (London, England)"},{"key":"90818_CR10","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.3390\/jcm11154581","volume":"11","author":"G Petzold","year":"2022","unstructured":"Petzold, G. Role of ultrasound methods for the assessment of NAFLD. J. Clin. Med. 11, 4581. https:\/\/doi.org\/10.3390\/jcm11154581 (2022).","journal-title":"J. Clin. Med."},{"key":"90818_CR11","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes, P. J. et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 156, 1717\u20131730. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.042 (2019).","journal-title":"Gastroenterology"},{"key":"90818_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2337\/dc20-1778","volume":"44","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo, S., Monti, T. & Perseghin, G. High prevalence of advanced liver fibrosis assessed by transient elastography among U.S. adults with type 2 diabetes. Diabetes Care 44, 519\u2013525. https:\/\/doi.org\/10.2337\/dc20-1778 (2021).","journal-title":"Diabetes Care"},{"key":"90818_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","volume":"17","author":"MS Siddiqui","year":"2019","unstructured":"Siddiqui, M. S. et al. Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol.: Off. Clin. Practice J. Am. Gastroenterol. Associat. 17, 156-163.e152. https:\/\/doi.org\/10.1016\/j.cgh.2018.04.043 (2019).","journal-title":"Clin. Gastroenterol. Hepatol.: Off. Clin. Practice J. Am. Gastroenterol. Associat."},{"key":"90818_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","volume":"143","author":"M Hamaguchi","year":"2005","unstructured":"Hamaguchi, M. et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. internal Med. 143, 722\u2013728. https:\/\/doi.org\/10.7326\/0003-4819-143-10-200511150-00009 (2005).","journal-title":"Ann. internal Med."},{"key":"90818_CR15","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1046\/j.1440-1746.2002.02846.x","volume":"17","author":"K Omagari","year":"2002","unstructured":"Omagari, K. et al. Fatty liver in non-alcoholic non-overweight Japanese adults: Incidence and clinical characteristics. J. Gastroenterol. Hepatol. 17, 1098\u20131105. https:\/\/doi.org\/10.1046\/j.1440-1746.2002.02846.x (2002).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"90818_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","volume":"227","author":"AP DeFilippis","year":"2013","unstructured":"DeFilippis, A. P. et al. Nonalcoholic fatty liver disease and serum lipoproteins: The multi-ethnic study of atherosclerosis. Atherosclerosis 227, 429\u2013436. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.01.022 (2013).","journal-title":"Atherosclerosis"},{"key":"90818_CR17","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/hep.23719","volume":"52","author":"BA Neuschwander-Tetri","year":"2010","unstructured":"Neuschwander-Tetri, B. A. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites. Hepatology (Baltimore, Md.) 52, 774\u2013788. https:\/\/doi.org\/10.1002\/hep.23719 (2010).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"90818_CR18","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1111\/liv.12318","volume":"34","author":"S Zelber-Sagi","year":"2014","unstructured":"Zelber-Sagi, S. et al. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease. Liver Int.: Off. J. Int. Associat. Study Liver 34, e128-135. https:\/\/doi.org\/10.1111\/liv.12318 (2014).","journal-title":"Liver Int.: Off. J. Int. Associat. Study Liver"},{"key":"90818_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12967-023-04291-4","volume":"21","author":"JH Lee","year":"2023","unstructured":"Lee, J. H., Kim, J., Kim, J. O. & Kwon, Y. J. Association of non-high-density lipoprotein cholesterol trajectories with the development of non-alcoholic fatty liver disease: An epidemiological and genome-wide association study. J. Transl. Med. 21, 435. https:\/\/doi.org\/10.1186\/s12967-023-04291-4 (2023).","journal-title":"J. Transl. Med."},{"key":"90818_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12876-022-02216-x","volume":"22","author":"Y Zou","year":"2022","unstructured":"Zou, Y., Hu, C., Kuang, M. & Chai, Y. Remnant cholesterol\/high-density lipoprotein cholesterol ratio is a new powerful tool for identifying non-alcoholic fatty liver disease. BMC Gastroenterol 22, 134. https:\/\/doi.org\/10.1186\/s12876-022-02216-x (2022).","journal-title":"BMC Gastroenterol"},{"key":"90818_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12944-019-1104-6","volume":"18","author":"Z Chen","year":"2019","unstructured":"Chen, Z., Qin, H., Qiu, S., Chen, G. & Chen, Y. Correlation of triglyceride to high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease among the non-obese Chinese population with normal blood lipid levels: A retrospective cohort research. Lipids Health Dis. 18, 162. https:\/\/doi.org\/10.1186\/s12944-019-1104-6 (2019).","journal-title":"Lipids Health Dis."},{"key":"90818_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12944-024-02143-8","volume":"23","author":"MY Tan","year":"2024","unstructured":"Tan, M. Y. et al. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio with type 2 diabetes mellitus: Recent findings from NHANES 2007\u20132018. Lipids Health Dis. 23, 151. https:\/\/doi.org\/10.1186\/s12944-024-02143-8 (2024).","journal-title":"Lipids Health Dis."},{"key":"90818_CR23","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1159\/000485861","volume":"42","author":"J Wen","year":"2017","unstructured":"Wen, J. et al. Association of the TG\/HDL-C and non-HDL-C\/HDL-C ratios with chronic kidney disease in an adult Chinese population. Kidney Blood Pressure Res. 42, 1141\u20131154. https:\/\/doi.org\/10.1159\/000485861 (2017).","journal-title":"Kidney Blood Pressure Res."},{"key":"90818_CR24","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.2147\/dmso.S355980","volume":"15","author":"G Sheng","year":"2022","unstructured":"Sheng, G. et al. Utility of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in evaluating incident diabetes risk. Diabetes, Metabol. Syndrome Obesity: Targets Therapy 15, 1677\u20131686. https:\/\/doi.org\/10.2147\/dmso.S355980 (2022).","journal-title":"Diabetes, Metabol. Syndrome Obesity: Targets Therapy"},{"key":"90818_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12944-022-01712-z","volume":"21","author":"S Lu","year":"2022","unstructured":"Lu, S. et al. Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population. Lipids Health Dis. 21, 95. https:\/\/doi.org\/10.1186\/s12944-022-01712-z (2022).","journal-title":"Lipids Health Dis."},{"key":"90818_CR26","first-page":"2569","volume":"13","author":"S Gao","year":"2020","unstructured":"Gao, S., Ramen, K., Yu, S. & Luo, J. Higher non-HDL-cholesterol to HDL-cholesterol ratio is linked to increase in non-alcoholic fatty liver disease: Secondary analysis based on a longitudinal study. Int. J. Clin. Exp. Pathol. 13, 2569\u20132575 (2020).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"90818_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12944-018-0848-8","volume":"17","author":"K Wang","year":"2018","unstructured":"Wang, K. et al. Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: A cohort study. Lipids Health Dis. 17, 196. https:\/\/doi.org\/10.1186\/s12944-018-0848-8 (2018).","journal-title":"Lipids Health Dis."},{"key":"90818_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jad.2023.10.064","volume":"344","author":"X Qi","year":"2024","unstructured":"Qi, X. et al. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and risk of depression among US adults: A cross-sectional NHANES study. J. Affect. Disorders 344, 451\u2013457. https:\/\/doi.org\/10.1016\/j.jad.2023.10.064 (2024).","journal-title":"J. Affect. Disorders"},{"key":"90818_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.925690","volume":"13","author":"R Xie","year":"2022","unstructured":"Xie, R. et al. Association between SII and hepatic steatosis and liver fibrosis: A population-based study. Front. Immunol. 13, 925690. https:\/\/doi.org\/10.3389\/fimmu.2022.925690 (2022).","journal-title":"Front. Immunol."},{"key":"90818_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24225","volume":"36","author":"N Yang","year":"2022","unstructured":"Yang, N., Lu, Y., Cao, L. & Lu, M. The association between non-alcoholic fatty liver disease and serum ferritin levels in American adults. J. Clin. Lab. Anal. 36, e24225. https:\/\/doi.org\/10.1002\/jcla.24225 (2022).","journal-title":"J. Clin. Lab. Anal."},{"key":"90818_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154752","volume":"121","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo, S. & Perseghin, G. Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes. Metabol. Clin. Exp. 121, 154752. https:\/\/doi.org\/10.1016\/j.metabol.2021.154752 (2021).","journal-title":"Metabol. Clin. Exp."},{"key":"90818_CR32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jhep.2007.11.020","volume":"48","author":"D Roulot","year":"2008","unstructured":"Roulot, D. et al. Liver stiffness values in apparently healthy subjects: Influence of gender and metabolic syndrome. J. Hepatol. 48, 606\u2013613. https:\/\/doi.org\/10.1016\/j.jhep.2007.11.020 (2008).","journal-title":"J. Hepatol."},{"key":"90818_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/783976","volume":"2011","author":"K Fon Tacer","year":"2011","unstructured":"Fon Tacer, K. & Rozman, D. Nonalcoholic Fatty liver disease: Focus on lipoprotein and lipid deregulation. J. Lipids 2011, 783976. https:\/\/doi.org\/10.1155\/2011\/783976 (2011).","journal-title":"J. Lipids"},{"key":"90818_CR34","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/hep.23593","volume":"51","author":"EK Speliotes","year":"2010","unstructured":"Speliotes, E. K. et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham Heart Study. Hepatology (Baltimore, Md.) 51, 1979\u20131987. https:\/\/doi.org\/10.1002\/hep.23593 (2010).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"90818_CR35","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki, N., Mikhailidis, D. P. & Mantzoros, C. S. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabol. Clin. Exp. 65, 1109\u20131123. https:\/\/doi.org\/10.1016\/j.metabol.2016.05.003 (2016).","journal-title":"Metabol. Clin. Exp."},{"key":"90818_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2021.101109","volume":"83","author":"H Li","year":"2021","unstructured":"Li, H., Yu, X. H., Ou, X., Ouyang, X. P. & Tang, C. K. Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis. Progr. Lipid Res. 83, 101109. https:\/\/doi.org\/10.1016\/j.plipres.2021.101109 (2021).","journal-title":"Progr. Lipid Res."},{"key":"90818_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bcp.2013.03.016","volume":"86","author":"S Ducheix","year":"2013","unstructured":"Ducheix, S., Montagner, A., Theodorou, V., Ferrier, L. & Guillou, H. The liver X receptor: A master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease. Biochem. Pharmacol. 86, 96\u2013105. https:\/\/doi.org\/10.1016\/j.bcp.2013.03.016 (2013).","journal-title":"Biochem. Pharmacol."},{"key":"90818_CR38","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/hep.23094","volume":"50","author":"K Fujita","year":"2009","unstructured":"Fujita, K. et al. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology (Baltimore, Md.) 50, 772\u2013780. https:\/\/doi.org\/10.1002\/hep.23094 (2009).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"90818_CR39","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/s0140-6736(19)32519-x","volume":"394","author":"FJ Brunner","year":"2019","unstructured":"Brunner, F. J. et al. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: Results from the Multinational Cardiovascular Risk Consortium. Lancet (London, England) 394, 2173\u20132183. https:\/\/doi.org\/10.1016\/s0140-6736(19)32519-x (2019).","journal-title":"Lancet (London, England)"},{"key":"90818_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104392","volume":"87","author":"I Ayada","year":"2023","unstructured":"Ayada, I. et al. Dissecting the multifaceted impact of statin use on fatty liver disease: A multidimensional study. EBioMedicine 87, 104392. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104392 (2023).","journal-title":"EBioMedicine"},{"key":"90818_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154770","volume":"119","author":"E Muzurovi\u0107","year":"2021","unstructured":"Muzurovi\u0107, E., Mikhailidis, D. P. & Mantzoros, C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabol. Clin. Exp. 119, 154770. https:\/\/doi.org\/10.1016\/j.metabol.2021.154770 (2021).","journal-title":"Metabol. Clin. Exp."},{"key":"90818_CR42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1172\/jci22422","volume":"114","author":"JD Browning","year":"2004","unstructured":"Browning, J. D. & Horton, J. D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Investigat. 114, 147\u2013152. https:\/\/doi.org\/10.1172\/jci22422 (2004).","journal-title":"J. Clin. Investigat."},{"key":"90818_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2014.02.006","volume":"234","author":"JA Lamprea-Montealegre","year":"2014","unstructured":"Lamprea-Montealegre, J. A. et al. Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: The ARIC study. Atherosclerosis 234, 42\u201346. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.02.006 (2014).","journal-title":"Atherosclerosis"},{"key":"90818_CR44","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1007\/s00125-010-1806-9","volume":"53","author":"MR Taskinen","year":"2010","unstructured":"Taskinen, M. R. et al. Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes. Diabetologia 53, 1846\u20131855. https:\/\/doi.org\/10.1007\/s00125-010-1806-9 (2010).","journal-title":"Diabetologia"},{"key":"90818_CR45","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.3390\/nu15132830","volume":"15","author":"YC Chen","year":"2023","unstructured":"Chen, Y. C. et al. Effect of vitamin D supplementation on primary dysmenorrhea: A systematic review and meta-analysis of randomized clinical trials. Nutrients 15, 2830. https:\/\/doi.org\/10.3390\/nu15132830 (2023).","journal-title":"Nutrients"},{"key":"90818_CR46","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.2147\/dmso.S414673","volume":"16","author":"R Zhen","year":"2023","unstructured":"Zhen, R. et al. The relationship between non-HDL-C \/HDL-C Ratio (NHHR) and vitamin D in type 2 diabetes mellitus. Diabetes, Metabol. Syndrome Obesity: Targets Therapy 16, 2661\u20132673. https:\/\/doi.org\/10.2147\/dmso.S414673 (2023).","journal-title":"Diabetes, Metabol. Syndrome Obesity: Targets Therapy"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90818-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90818-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90818-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T14:17:08Z","timestamp":1741789028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90818-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90818"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90818-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This is an observational study. The studies involving human participants were reviewed and approved by the NCHS Ethics Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"8462"}}